Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 299, Issue 5, 2010, Pages

  Planche, Timothy ^a,b   Macallan, Derek C ^a   Sobande, Toni ^a   Borrmann, Steffen ^b,c   Kun, Jürgen F J ^d   Krishna, Sanjeev ^a,b   Kremsner, Peter G ^b,d  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ALBERT SCHWEITZER HOSPITAL   (Gabon)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Malaria; Nitric oxide; Nitric oxide synthase; Polymorphism

Indexed keywords

ARGININE; CYSTEINE; FANSIDAR; GLYCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITROGEN; NITROGEN 15;

AMINO ACID SUBSTITUTION; ARTICLE; ATOM; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; GABON; GENOTYPE; HETEROZYGOTE; HUMAN; IN VIVO STUDY; MALARIA; MALE; NITROGEN UPTAKE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; RISK REDUCTION; SCHOOL CHILD; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; URINALYSIS; URINE; URINE VOLUME;

ARGININE; CHILD; CHILD, PRESCHOOL; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALARIA; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITROGEN ISOTOPES; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78149476238     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00390.2010     Document Type: Article

References (32)

1. Agbenyega T, Angus B, Bedu-Addo G, Baffoe-Bonnie B, Griffin G, Vallance P, Krishna S. Comparison of plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria. Trans R Soc Trop Med Hyg 91: 298-302, 1997.
2. Balmer P, Phillips HM, Maestre AE, McMonagle FA, Phillips RS. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P berghei in vitro. Parasite Immunol 22: 97-106, 2000.
3. Boutlis CS, Hobbs MR, Marsh RL, Misukonis MA, Tkachuk AN, Lagog M, Booth J, Granger DL, Bockarie MJ, Mgone CS, Levesque MC, Weinberg JB, Anstey NM. Inducible nitric oxide synthase (NOS2) promoter CCTTT repeat polymorphism: relationship to in vivo nitric oxide production/NOS activity in an asymptomatic malaria-endemic population. Am J Trop Med Hyg 69: 569-573, 2003.
4. Burgner D, Rockett K, Ackerman H, Hull J, Usen S, Pinder M, Kwiatkowski DP. Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations. Genes Immun 4: 506-514, 2003. (Pubitemid 38967618)
5. Burgner D, Xu W, Rockett K, Gravenor M, Charles IG, Hill AV, Kwiatkowski D. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 352: 1193-1194, 1998.
6. Clarke I, Alleva L. Is human malarial coma caused, or merely deepened, by sequestration? Trends Parasitol 25: 314-318, 2009.
7. Cramer JP, Nussler AK, Ehrhardt S, Burkhardt J, Otchwemah RN, Zanger P, Dietz E, Gellert S, Bienzle U, Mockenhaupt FP. Agedependent effect of plasma nitric oxide on parasite density in Ghanaian children with severe malaria. Trop Med Int Health 10: 672-680, 2005.
8. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96: 60-68, 1995.
9. Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit MR. The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection. Parasitol Res 104: 1315-1320, 2009.
10. Ganster RW, Taylor BS, Shao L, Geller DA. Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB. Proc Natl Acad Sci USA 98: 8638-8643, 2001.
11. Gehan S, George S. Estimation of body surface area from height and weight. Cancer Chemother Rep 54: 225-235, 1970.
12. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, Intaglietta M, van der Heyde HC. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 12: 1417-1422, 2006.
13. Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360: 1468-1475, 2002.
14. Jackson SJ, Siervo M, Persson E, McKenna LM, Bluck LJ. A novel derivative for the assessment of urinary and salivary nitrate using gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 22: 4158-4164, 2008.
15. Keller CC, Kremsner PG, Hittner JB, Misukonis MA, Weinberg JB, Perkins DJ. Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun 72: 4868-4873, 2004.
16. Kremsner PG, Winkler S, Wildling E, Prada J, Bienzle U, Graninger W, Nussler AK. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 90: 44-47, 1996. (Pubitemid 26069445)
17. Kun JF, Mordmuller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG. Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184: 330-336, 2001.
18. Kun JFK, Mordmüller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in promotor region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351: 265-266, 1998.
19. Levesque MC, Hobbs MR, Anstey NM, Vaughn TN, Chancellor JA, Pole A, Perkins DJ, Misukonis MA, Chanock SJ, Granger DL, Weinberg JB. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis 180: 1994-2002, 1999.
20. Levesque MC, Hobbs MR, O'Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB. Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Hum Genet 127: 163-182, 2010.
21. Lopansri BK, Anstey NM, Weinberg JB, Stoddard GJ, Hobbs MR, Levesque MC, Mwaikambo ED, Granger DL. Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet 361: 676-678, 2003.
22. 2]arginine: application to the response to vaccination. Am J Physiol Regul Integr Comp Physiol 272: R1888-R1896, 1997.
23. Parikh S, Dorsey G, Rosenthal PJ. Host polymorphisms and the incidence of malaria in Ugandan children. Am J Trop Med Hyg 71: 750-753, 2004.
24. Planche T, Onanga M, Schwenk A, Dzeing A, Borrmann S, Faucher JF, Wright A, Bluck L, Ward L, Kombila M, Kremsner PG, Krishna S. Assessment of volume depletion in children with malaria. PLoS Med 1: e18, 2004.
25. Rockett KA, Awburn MM, Cowden WB, Clark IA. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun 59: 3280-3283, 1991.
26. Serirom S, Raharjo WH, Chotivanich K, Loareesuwan S, Kubes P, Ho M. Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol 162: 1651-1660, 2003.
27. Tobin MD, Minelli C, Burton PR, Thompson JR. Commentary: development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding'. Int J Epidemiol 33: 26-29, 2004.
28. Wagner DA, Schultz DS, Deen WM, Young VR, Tannenbaum SR. Metabolic fate of an oral dose of 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Cancer Res 43: 1921-1925, 1983.
29. Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL. Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis 21: 468-475, 2008.
30. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med 204: 2693-2704, 2007.
31. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, Darcy CJ, Granger DL, Weinberg JB, Lopansri BK, Price RN, Duffull SB, Celermajer DS, Anstey NM. Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J Infect Dis 198: 602-608, 2008.
32. Yeo TW, Rooslamiati I, Gitawati R, Tjitra E, Lampah DA, Kenangalem E, McNeil YR, Price RN, Anstey NM, Duffull SB. Pharmacokinetics of L-arginine in adults with moderately severe malaria. Antimicrob Agents Chemother 52: 4381-4387, 2008.